Table 2.
Summary of study results regarding HIV-1 reactivation and the viral reservoir of published clinical studies on people with HIV-1 exposed to latency reversing agents grouped according to their mechanism of action.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.